# Rodney J. Hicks

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rodney-j-hicks/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,371 |
| Field | Medical Imaging Techniques and Applications |
| h-index | 98 |
| i10-index | 491 |
| Last Known Institution | The University of Melbourne |
| OpenAlex ID | https://openalex.org/A5060586557 |
| ORCID iD | 0000-0002-0758-0824 |
| Works | 1,013 |

## Researcher papers

Showing 12 of 21.

- [Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study](https://scholariq.org/papers/prostate-specific-membrane-antigen-pet-ct-in-patients-with-high-risk-prostate/)
- [Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group](https://scholariq.org/papers/role-of-imaging-in-the-staging-and-response-assessment-of-lymphoma-consensus-of/)
- [Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma](https://scholariq.org/papers/use-of-positron-emission-tomography-for-response-assessment-of-lymphoma/)
- [\[177Lu\]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study](https://scholariq.org/papers/177lu-psma-617-radionuclide-treatment-in-patients-with-metastatic-castration/)
- [Delivering affordable cancer care in high-income countries](https://scholariq.org/papers/delivering-affordable-cancer-care-in-high-income-countries/)
- [Somatostatin Receptor Imaging with<sup>68</sup>Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation](https://scholariq.org/papers/somatostatin-receptor-imaging-with-sup-68-sup-ga-dotatate-pet-ct-clinical/)
- [Prognostic Significance of \[<sup>18</sup>F\]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02](https://scholariq.org/papers/prognostic-significance-of-sup-18-sup-f-misonidazole-positron-emission/)
- [ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging](https://scholariq.org/papers/enets-consensus-guidelines-for-the-standards-of-care-in-neuroendocrine-tumors/)
- [Dosimetry of <sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes](https://scholariq.org/papers/dosimetry-of-sup-177-sup-lu-psma-617-in-metastatic-castration-resistant-prostate/)
- [Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non–Small-Cell Lung Cancer](https://scholariq.org/papers/positron-emission-tomography-is-superior-to-computed-tomography-scanning-for/)
- [EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)](https://scholariq.org/papers/eanm-procedure-guidelines-for-radionuclide-therapy-with-177lu-labelled-psma/)
- [ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues](https://scholariq.org/papers/enets-consensus-guidelines-for-the-standards-of-care-in-neuroendocrine-neoplasms/)

## Researcher topics

- [Medical Imaging Techniques and Applications](https://scholariq.org/topics/medical-imaging-techniques-and-applications/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Researcher university

- [The University of Melbourne](https://scholariq.org/institutions/the-university-of-melbourne/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.